Metformin × all-cause mortality

TrialLancet (London, England)1998

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.

PubMed ↗

What the trial testedas reported · 4,416 people · 1998

Not counted

Reduced deaths

−32.0percentage points−47.0 to −13.0

As reported

difference −32.0 %, 95% CI −47.0 to −13.0 · the paper's word: All-cause mortality

One number in the abstract

the abstract, start to end

group, had risk reductions of 32% (95% CI 13-47, p=0.002) for

← favours treatmentfavours comparator →
could be chance
All-cause mortality
−32.0−47.0 to −13.0
MetforminAll-cause mortality
1 / 3

2,345 papers cite itlatest 60 shown

1998
2024
2025
2026
this paperpooled ittrialcites it

13 trials

Full record →Abstract, authors, funding and every citing paper · PMID 9742977